AMD1 and posterior cortical atrophy: Finally, elevated levels of AMD1 and its product dcSAM are manifest in PCa having activated mTORC1, and treatment with mTORC1 inhibitors provokes reductions in half-life of proAMD1 and this response can be reversed by proteasome inhibitors.